Page 1074 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

61. Japiassu AM, Amancio RT, Mesquita EC, et al. Sepsis is a major 78. Montaner JS, Russell JA, Lawson L, Ruedy J. Acute respiratory
determinant of outcome in critically ill HIV/AIDS patients. Crit failure secondary to Pneumocystis carinii pneumonia in the
Care. 2010;14:R152. acquired immunodeficiency syndrome: a potential role for sys-
62. Hull MW, Phillips P, Montaner JS. Changing global epide- temic corticosteroids. Chest. 1989;95:881-884.
miology of pulmonary manifestations of HIV/AIDS. Chest. 79. Levine SJ, White DA. Pneumocystis carinii. Clin Chest Med.
2008;134:1287-1298. 1988;9:395-423.
63. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneu- 80. Young KR Jr, Rankin JA, Naegel GP, Paul ES, Reynolds HY.
monia in persons infected with the human immunodeficiency Bronchoalveolar lavage cells and proteins in patients with
virus. Pulmonary Complications of HIV Infection Study Group. the acquired immunodeficiency syndrome: an immunologic
N Engl J Med. 1995;333:845-851. analysis. Ann Intern Med. 1985;103:522-533.
64. Mayaud C, Parrot A, Cadranel J. Pyogenic bacterial lower 81. Telzak EE, Cote RJ, Gold JW, Campbell SW, Armstrong D.
respiratory tract infection in human immunodeficiency virus- Extrapulmonary Pneumocystis carinii infections. Rev Infect Dis.
infected patients. Eur Respir J Suppl. 2002;36:28s-39s. 1990;12:380-386.
65. Park DR, Sherbin VL, Goodman MS, et al. The etiology of 82. Panel on opportunistic infections in HIV-infected adults and
community-acquired pneumonia at an urban public hospital: adolescents. Guidelines for the prevention and treatment of
influence of human immunodeficiency virus infection and ini- opportunistic infections in HIV-infected adults and adoles-
tial severity of illness. J Infect Dis. 2001;184:268-277. cents: recommendations from the Centers for Disease Control
66. Rimland D, Navin TR, Lennox JL, et al. Prospective study of and Prevention, the National Institutes of Health, and the
etiologic agents of community-acquired pneumonia in patients HIV Medicine Association of the Infectious Diseases Society
with HIV infection. AIDS. 2002;16:85-95. of America. May 8, 2013. http://aidsinfo.nih.gov/contentfiles/
lvguidelines/adultoi.pdf. Accessed July 16, 2013.
67. Allen SH, Brennan-Benson P, Nelson M, et al. Pneumonia
due to antibiotic resistant Streptococcus pneumoniae and 83. Wharton JM, Coleman DL, Wofsy CB, et al. Trimethoprim-
Pseudomonas aeruginosa in the HAART era. Postgrad Med J. sulfamethoxazole or pentamidine for Pneumocystis
2003;79:691-694. carinii pneumonia in the acquired immunodeficiency syn-
drome: a prospective randomized trial. Ann Intern Med.
68. Le Moing V, Rabaud C, Journot V, et al. Incidence and risk fac- 1986;105:37-44.
tors of bacterial pneumonia requiring hospitalization in HIV-
infected patients started on a protease inhibitor-containing 84. Medina I, Mills J, Leoung G, et al. Oral therapy for Pneumocystis
regimen. HIV Med. 2006;7:261-267. carinii pneumonia in the acquired immunodeficiency syn-
drome: a controlled trial of trimethoprim- sulfamethoxazole
69. Curran A, Falco V, Crespo M, et al. Bacterial pneumonia in versus trimethoprim-dapsone. N Engl J Med. 1990;323:
HIV-infected patients: use of the pneumonia severity index 776-782.
and impact of current management on incidence, aetiology and
outcome. HIV Med. 2008;9:609-615. 85. Montaner JSG, Zala C. The role of the laboratory in the diag-
nosis and management of AIDS-related Pneumocystis carinii
70. Sogaard OS, Lohse N, Gerstoft J, et al. Hospitalization for pneumonia. Ballieres Clin Infect. 1995;2(3):471-485.
pneumonia among individuals with and without HIV infec-
tion, 1995-2007: a Danish population-based, nationwide cohort 86. Hughes W, Leoung G, Kramer F, et al. Comparison of atova-
study. Clin Infect Dis. 2008;47:1345-1353. quone (566C80) with trimethoprim-sulfamethoxazole to treat
Pneumocystis carinii pneumonia in patients with AIDS. N Engl
71. Ventilation with lower tidal volumes as compared with tra- J Med. 1993;328:1521-1527.
ditional tidal volumes for acute lung injury and the acute
respiratory distress syndrome. The Acute Respiratory Distress 87. Consensus statement on the use of corticosteroids as adjunctive
Syndrome Network. N Engl J Med. 2000;342:1301-1308. therapy for pneumocystis pneumonia in the acquired immu-
nodeficiency syndrome. The National Institutes of Health-
72. Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin University of California Expert Panel for Corticosteroids as
ML. Ribosomal RNA sequence shows Pneumocystis carinii to Adjunctive Therapy for Pneumocystis Pneumonia. N Engl J
be a member of the fungi. Nature. 1988;334:519-522.
Med. 1990;323:1500-1504.
73. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J 88. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW,
Med. 2004;350:2487-2498.
La Voie L. Corticosteroids as adjunctive therapy for severe
74. Morris A, Lundgren JD, Masur H, et al. Current epidemiology of Pneumocystis carinii pneumonia in the acquired immunode-
Pneumocystis pneumonia. Emerg Infect Dis. 2004;10:1713-1720. ficiency syndrome: a double-blind, placebo-controlled trial.
75. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The N Engl J Med. 1990;323:1444-1450.
risk of Pneumocystis carinii pneumonia among men infected 89. Montaner JS, Lawson LM, Levitt N, Belzberg A, Schechter MT,
with human immunodeficiency virus type 1. Multicenter AIDS Ruedy J. Corticosteroids prevent early deterioration in patients
Cohort Study Group. N Engl J Med. 1990;322:161-165. with moderately severe Pneumocystis carinii pneumonia and
76. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology the acquired immunodeficiency syndrome (AIDS). Ann Intern
of human immunodeficiency virus-associated opportunistic Med. 1990;113:14-20.
infections in the United States in the era of highly active anti- 90. Ledergerber B, Mocroft A, Reiss P, et al. Discontinuation of
retroviral therapy. Clin Infect Dis. 2000;30(suppl 1):S5-S14. secondary prophylaxis against Pneumocystis carinii pneumonia
77. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS in patients with HIV infection who have a response to antiret-
and death rates in the EuroSIDA study: an observational study. roviral therapy. Eight European Study Groups. N Engl J Med.
Lancet. 2003;362:22-29. 2001;344:168-174.

Section05-O-ref.indd 3 1/20/2015 4:51:21 PM